Alternative treatment of resistant hypoparathyroidism by intermittent infusion of teriparatide using an insulin pump: A case report

Özet

Hypoparathyroidism usually responds to oral active vitamin D and calcium, but, although rare, some patients do not respond to thistreatment. A 47-year-old Caucasian female presented to our medical unit with classical oral treatment-resistant hypocalcemia afterthyroidectomy. Teriparatide was infused through the insulin pump with dosage set to 1 unit which equals to 2.5 μg of teriparatide.In conclusion, intermittent subcutaneous infusion of teriparatide using an insulin pump is a safe and effective treatment modality toensure normocalcemic conditions in patients with classical treatment-resistant hypoparathyroidism.